Australia's largest stock trading and investment forum Australia's #1 stock forum

RAP

0.00%

20.5¢ raptor resources limited

Ann: Publication on challenges of diagnosing respiratory disease, page-21

Currently unlisted. Proposed listing date: 4 SEPTEMBER 2024 #

First 21 Last

Share
Profile

Follow
Jezza59

576 Posts.

73

20/11/21

09:15

Post #: 57718869
Share

Originally posted by kingkongtrader: ↑

To be honest, innovating in this day and age is hard. It takes so much effort to come up with something new, novel and useful that can address a real world problem. There will be many challenges, dollar and time spent and sometimes wasted.
There might be no dollar figure or value in this post, but i believe, being a scientific published journal, it sheds light on the magnitude of the problem the firm is teying to address with their novel solution.
I too, deeply believe in this company. I believe with the digitisation of services, their mobile hearing via phone really bridge the gap for in person consultation and online consultant.
It is obvious they have been just surviving, with barely any revenue and high chance for another CR. But dyson or tesla or any of those novel innovative company all started the same. Trying to burn cash in exchange for a technological break through and advancement in modern technological capabilities. Hence, even with a CR, I do hope that there will soon be light at the end of the tunnel as shown by increasing license agreement with various medical companies.
Just some of my opinion. Thanks

Expand

Great post this is now the validation process. In my opinion this is just the beginning if they get it right shareholders will be rewarded I hope specially the long term investors GLTA

RAP Price at posting: 5.5¢ Sentiment: Buy Disclosure: Held
5 Upvote

0 Great analysis

Reply

Top Stories

KAL

KalGold rolls out detailed aeromagnetic survey across Pinjin project

The market's shrugged at China's stimulus measures all year. Why is this one different?

NAM

ACCC seeks Olam divestments before it can buy Namoi Cotton

Week 39 Wrap: What HotCopper’s watching; China’s new stimmy moves boost metals; Oz CPI drop

STK

5.6g/t gold intercept at Serbia's Rogozna supports Strickland's hopes for high-grade core

The winners & losers on market if negative gearing were gone

COD

Coda Minerals (ASX:COD) enters rights issue to further exploration in South Australia

ESR

Estrella first foreign entity to win tenements in Timor-Leste under new laws ahead of 2025 tenders

ACW

Actinogen Medical ramps up Alzheimer’s treatment trials, targeting fast-track global approvals

DEG

HotCopper users muse on De Grey's denial of Agnico Eagle takeover bid – but who are Agnico?

There are more pages in this discussion • 24 more messages in this thread...

First 21 Last

Add RAP (ASX) to my watchlist

Ann: Publication on challenges of diagnosing respiratory disease, page-21

Top Stories

KalGold rolls out detailed aeromagnetic survey across Pinjin project

The market's shrugged at China's stimulus measures all year. Why is this one different?

ACCC seeks Olam divestments before it can buy Namoi Cotton

Week 39 Wrap: What HotCopper’s watching; China’s new stimmy moves boost metals; Oz CPI drop

5.6g/t gold intercept at Serbia's Rogozna supports Strickland's hopes for high-grade core

The winners & losers on market if negative gearing were gone

Coda Minerals (ASX:COD) enters rights issue to further exploration in South Australia

Estrella first foreign entity to win tenements in Timor-Leste under new laws ahead of 2025 tenders

Actinogen Medical ramps up Alzheimer’s treatment trials, targeting fast-track global approvals

HotCopper users muse on De Grey's denial of Agnico Eagle takeover bid – but who are Agnico?

Featured News